Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 2Graft vs Host Disease 1

Interventions

Cyclophosphamide 62Tacrolimus 52Methotrexate 39Mycophenolic Acid 36Busulfan 35fludarabine phosphate 34Cyclosporine 32Antilymphocyte Serum 32fludarabine 28Sirolimus 23Peripheral Blood Stem Cell Transplantation 22Melphalan 22Radiotherapy 21Methylprednisolone 20Whole-Body Irradiation 19Filgrastim 17thymoglobulin 14Thiotepa 10Stem Cell Transplantation 9Granulocyte Colony-Stimulating Factor 9Hematopoietic Stem Cell Transplantation 7Cord Blood Stem Cell Transplantation 7ruxolitinib 6Rituximab 6Etoposide 6Transplantation 5Therapeutics 5Prednisone 5Flow Cytometry 5Cytarabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Semustine × Other hematologic neoplasm × Clear all
NCT04688021 2023-02-21

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

First Affiliated Hospital of Zhejiang University

Phase 2 Unknown
46 enrolled
Other hematologic neoplasm

Graft vs Host Disease, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡